ASHLEE DOWNEY: Open Payments
NPI 1477021038 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 49 payments from 19 companies in 2025. Trend: 2023 $285 · 2024 $542 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $159 |
| Novo Nordisk Inc | 8 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| ABBVIE INC. | 5 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Lilly USA, LLC | 3 | $56 |
| Inspire Medical Systems, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: OTEZLA, Wegovy, CAPLYTA, VRAYLAR, Kerendia, INSPIRE, REXULTI, MOUNJARO.
Industry payments across TN — which companies pay providers there.
